Physician profile
Weems Pennington
NPI 1215027263
$3,982.39
in general payments reported to CMS, 2019-2025
39 companies · $664 in 2025
The $664 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,086 · 2020: $202 · 2021: $284 · 2022: $498 · 2023: $681 · 2024: $569 · 2025: $664.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,913.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,913.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,216.37 | 2019-2025 | Watchman Flx, Watchman Access System, Cds Broad Portfolio Offering |
| Novartis Pharmaceuticals Corporation | $331.82 | 2019-2025 | |
| Pfizer INC. | $276.12 | 2019-2025 | |
| Abbott Laboratories | $260.76 | 2019-2025 | Diamondback Coronary, Pressurewire, Aveir |
| Abiomed | $165.68 | 2024-2025 | |
| E.R. Squibb & Sons, L.L.C. | $152.49 | 2021-2025 | Camzyos |
| Astrazeneca Pharmaceuticals LP | $148.56 | 2019-2022 | |
| Cardiovascular Systems INC. | $130.91 | 2019-2023 | Diamondback Coronary |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $124.69 | 2023-2025 | Lifevest |
| Amgen INC. | $123.56 | 2019-2020 | |
| Inari Medical, INC. | $110.42 | 2022-2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Medtronic, INC. | $109.46 | 2022-2025 | Micra, Cobalt Dr Mri Surescan, Valiant Captivia |
| Sanofi-Aventis U.S. LLC | $77.42 | 2019 | |
| Janssen Pharmaceuticals, INC | $62.43 | 2019-2023 | Xarelto |
| Astellas Pharma US INC | $55.55 | 2020 |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $53.58 | 2025 | Flowtriever, Clottriever Bold Catheter |
| Kiniksa Pharmaceuticals, LTD. | $51.34 | 2022-2023 | Arcalyst |
| Penumbra, INC. | $45.62 | 2025 | Indigo System |
| Daiichi Sankyo INC. | $44.02 | 2019-2025 | Injectafer |
| Novo Nordisk INC | $40.44 | 2023-2025 | Wegovy, Ozempic, Rybelsus |
| Veryan Medical Incorporated | $37.55 | 2023 | Biomimics 3d Vascular Stent System |
| Kiniksa Pharmaceuticals International, Plc | $34.69 | 2024 | Arcalyst |
| Shockwave Medical, INC | $32.02 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Medtronic Vascular, INC. | $25.99 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $25.80 | 2019 | |
| Arbor Pharmaceuticals, INC. | $24.82 | 2019-2020 | |
| W. L. Gore & Associates, INC. | $24.62 | 2025 | Gore Viabahn Vbx Balloon Expandable Endo |
| Vital Connect, INC | $20.70 | 2022 | |
| Cardiva Medical, INC. | $19.64 | 2023 | Cardiva Vascade Mvp Vvcs 6-12f |
| Chiesi USA, INC. | $17.95 | 2019 | |
| Biotronik INC. | $17.07 | 2022 | |
| Getinge USA Sales, LLC | $16.67 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $16.63 | 2024 | |
| Solventum Corporation | $16.58 | 2025 | Activ.A.C., Promogran Prisma |
| Lundbeck LLC | $15.39 | 2019 | |
| Baxter Healthcare | $15.05 | 2023 | Hillrom - Carnation Ambulatory Monitor |
| Itamar Medical INC | $14.76 | 2021 | |
| Amarin Pharma, INC. | $13.71 | 2019 | |
| Merck Sharp & Dohme LLC | $11.51 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Weems Pennington listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.